Thermo Fisher Scientific has introduced the Applied Biosystems InnoviGene Suite, an intuitive, browser-based software platform to automate and optimize capillary electrophoresis (CE) data analysis that enables 21 CFR Part 11 compliance.
First launching with capabilities for Sanger sequencing, InnoviGene Suite enables researchers and scientists to efficiently manage and analyze their sequencing data, ensuring reliable results and sharing customizable reports. The InnoviGene Suite initiates data exchange and analysis as soon as a run is complete, helping limit manual work that may lead to errors. Automated data tools such as quality control, confirmation, and mismatch detection can deliver improved efficiency and accuracy to optimize Sanger analysis.
InnoviGene software can be accessed within or outside the lab network through a browser, enabling collaboration within teams while supporting the security and privacy of data. Up to five users can access the platform at a time, connecting any number of CE instruments across a lab for increased collaboration and access to complete data.
Features:
· Enables 21 CFR Part 11 compliance
· AI-based basecalling
· Data automation
· Browser-based access
· Customizable reports
